Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxy-TB
NCT05473520Phase 3Recruiting
- Sponsor
- National University Hospital
- Start
- May 2023
- Primary completion
- Jan 2030
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of doxycycline in pulmonary tuberculosis (TB), sponsored by National University Hospital. Started May 2023; status: recruiting.
02
Drugs
doxycycline
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT05473520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05473520.